Overview Financials News + Filings IR Vault Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
CC transcript
Auditor change
Appointed CFO
|
|
SCICLONE PHARMACEUTICALS INC (SCLN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/17/2017 |
SC 13D/A
| Man Group plc reports a 0% stake in SciClone Pharmaceuticals, Inc. |
| 10/16/2017 |
SC 13D/A
| GL Partners Capital Management Ltd reports a 0% stake in SCICLONE PHARMACEUTICALS, INC. |
| 06/08/2017 |
SC 13D/A
| GL Partners Capital Management Ltd reports a 9.2% stake in SCICLONE PHARMACEUTICALS, INC. |
| 02/21/2017 |
SC 13D/A
| Jade Park Investments Ltd reports a 0% stake in SCICLONE PHARMACEUTICALS, INC. |
| 02/17/2017 |
SC 13D/A
| Ally Bridge LB Healthcare Master Fund Ltd reports a 1.3% stake in SCICLONE PHARMACEUTICALS, INC. |
| 02/17/2017 |
SC 13D/A
| GL Partners Capital Management Ltd reports a 9.3% stake in SCICLONE PHARMACEUTICALS, INC. |
| 11/15/2016 |
SC 13D/A
| Jade Park Investments Ltd reports a 0% stake in SCICLONE PHARMACEUTICALS, INC. |
| 11/14/2016 |
SC 13D/A
| Ally Bridge LB Healthcare Master Fund Ltd reports a 1.3% stake in SCICLONE PHARMACEUTICALS, INC. |
| 11/14/2016 |
SC 13D/A
| GL Partners Capital Management Ltd reports a 9.3% stake in SCICLONE PHARMACEUTICALS, INC. |
| 05/02/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 07/18/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 07/13/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 03/31/2009 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 01/02/2009 |
SC 13D/A
| SIGMA TAU FINANZIARIA SPA reports a 21.3% stake in SciClone Pharmaceuticals, Inc. |
|
|